Financial Burden of Cancer Care

Last Updated:

On This Page:

No trend data are available for financial burden of cancer care

Introduction

The financial costs of cancer care are a burden to people diagnosed with cancer, their families, and society as a whole. National expenditures associated with cancer have been steadily increasing in the United States. Care for cancer survivors accounted for an estimated 137.4 billion in medical care expenditures in the United States in 2010. In the near future, cancer costs may increase at a faster rate than overall medical expenditures. As the population ages, cancer prevalence and the absolute number of people treated for cancer will increase even if cancer incidence rates remain constant or decrease somewhat. Costs are also likely to increase as new, more advanced, and more expensive treatments are adopted as standards of care.

The national economic burden of cancer care in 2016 is shown below for bladder, brain, female breast, cervical, colorectal, esophageal, head and neck, kidney, lung, ovarian, pancreatic, prostate, stomach, and uterine cancers, as well as lymphoma, leukemia, and melanoma. All other cancers are combined as a single category.

National expenditures were largest for lymphoma and female breast, colorectal, prostate, and lung cancers, reflecting prevalence of disease, treatment patterns, and costs for different types of care.

Measure

Estimates of national expenditures for cancer care.

Healthy People 2020 Target

  • There is no Healthy People 2020 target for the financial burden of cancer care.

Healthy People 2020 is a set of goals set forth by the Department of Health and Human Services.

Data Source

Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML. Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst 2008; 100: 1763-70.

Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst 2011;103(2): 117–28.

Warren, JL, Yabroff KR, Meekins A, Topor M, Lamont E, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst 2008; 100: 888-897.

Trends and Most Recent EstimatesHelp with navigating the graphs and data tables

Cost of Cancer Care

By Cancer Site
Estimates of national expenditures for cancer care in 2016 (in billions of dollars) by cancer site
Overview graph Cancer Site Expenditures(billion)
Thumbnail of graph for Estimates of national expenditures for cancer care in 2016 (in billions of dollars) by cancer site Female Breast 18.9
Colorectal 15.9
Prostate 14.3
Lymphoma 14.0
Lung 13.6
Leukemia 6.3
Ovary 5.7
Brain 5.1
Kidney 4.6
Bladder 4.5
Head and Neck 4.0
Uterus 2.8
Melanoma 2.8
Pancreas 2.6
Stomach 2.1
Esophagus 1.6
Cervix 1.5
All Other Sites 23.5
By Cancer Site and Phase of Care
Estimates of national expenditures for cancer care in 2016 (in billions of dollars) by cancer site and phase of care
Overview graph Cancer Site Last year of life Continuing care Initial care
Thumbnail of graph for Estimates of national expenditures for cancer care in 2016 (in billions of dollars) by cancer site and phase of care Female Breast 4.3 8.0 6.5
Colorectal 4.8 4.4 6.6
Prostate 1.3 7.6 5.4
Lymphoma 4.8 5.7 3.5
Lung 5.6 2.1 5.9
Leukemia 3.0 2.5 0.9
Ovary 2.4 1.8 1.5
Brain 2.5 1.2 1.4
Kidney 1.3 2.0 1.3
Bladder 1.2 2.1 1.1
Head and Neck 1.7 1.1 1.2
Uterus 0.8 0.8 1.2
Melanoma 0.4 1.9 0.5
Pancreas 0.9 0.1 1.6
Stomach 0.9 0.3 0.9
Esophagus 0.7 0.2 0.7
Cervix 0.7 0.4 0.5
All Other Sites 6.2 13.0 4.3
Distribution of Cost by Cancer Site
Estimates of the proportion of national expenditures for cancer care in 2016 by cancer site and phase of care
Overview graph Cancer Site Last year of life Continuing care Initial care
Thumbnail of graph for Estimates of the proportion of national expenditures for cancer care in 2016 by cancer site and phase of care Female Breast 22.9 42.5 34.6
Colorectal 30.3 27.9 41.8
Prostate 9.2 53.2 37.6
Lymphoma 34.5 40.6 24.9
Lung 41.4 15.2 43.4
Leukemia 47.0 39.2 13.8
Ovary 41.4 32.4 26.2
Brain 48.8 24.3 27.0
Kidney 29.1 42.8 28.1
Bladder 27.7 47.4 24.9
Head and Neck 42.5 27.8 29.7
Uterus 28.5 29.7 41.8
Melanoma 13.3 67.7 19.0
Pancreas 33.2 5.1 61.8
Stomach 41.8 12.8 45.5
Esophagus 46.8 11.9 41.3
Cervix 44.3 23.5 32.2
All Other Sites 26.3 55.4 18.3
All Sites 30.3 38.4 31.3

Medicare Payments During First Year After Cancer Diagnosis

Percentage of Medicare payments in the first year following diagnosis for cancer care by type of service in 2002
Overview graph Cancer Site Cancer Related Surgery Chemotherapy Radiation therapy Other hospitalizations Other services
Thumbnail of graph for Percentage of Medicare payments in the first year following diagnosis for cancer care by type of service in 2002 Female Breast 24.6 14.8 11.0 18.3 31.3
Lung 16.6 20.4 3.3 33.6 26.1
Colorectal 53.1 9.2 0.9 18.4 18.4
Prostate 11.8 2.3 14.4 21.4 50.1

Lost Productivity Due to Cancer Diagnosis

Lost productivity due to cancer deaths in the United States among adults aged 20 years and older, 2005
Overview graph Cancer Site Present value of lifetime earnings (billion)
Thumbnail of graph for Lost productivity due to cancer deaths in the United States among adults aged 20 years and older, 2005 Lung and bronchus 36.1
Female breast 12.1
Colon and rectum 10.7
Pancreas 6.6
Brain and ONS 5.7
Leukemia 5.7
Non-Hodgkin lymphoma 5.5
Liver and intrahepatic bile duct 4.4
Kidney and renal pelvis 3.4
Head and neck 3.4
Prostate 3.3
Stomach 3.2
Melanoma of the skin 3.2
Ovary 2.8
Cervix uteri 1.8
Urinary bladder 1.8
Corpus and uterus 1.0
Hodgkin lymphoma 0.8
Testis 0.5
All other sites 22.5

Additional Information on the Financial Burden of Cancer Care

Scientific reports

Year Range

2015

Recent Summary Trend Year Range

No trend data are available for the financial burden of cancer care.

Summary Tables

The Economic Burden of Cancer

Recent Summary Trend

n/a

Desired Direction

Falling